Alliqua Company Profile (NASDAQ:ALQA)

Analyst Ratings

Consensus Ratings for Alliqua (NASDAQ:ALQA) (?)
Ratings Breakdown: 5 Buy Rating(s)
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $3.05 (169.91% upside)

Analysts' Ratings History for Alliqua (NASDAQ:ALQA)
Show:
DateFirmActionRatingPrice TargetActions
7/10/2016Chardan CapitalReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/11/2016HC WainwrightReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/26/2016Northland SecuritiesLower Price TargetOutperform$7.00 -> $3.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/26/2016Craig HallumLower Price TargetBuy$3.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/24/2016Royal Bank Of CanadaLower Price TargetOutperform$6.00 -> $3.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/26/2015Cowen and CompanyInitiated CoverageOutperform$9.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 7/28/2014 forward)

Earnings

Earnings History for Alliqua (NASDAQ:ALQA)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallActions
8/4/2016        
5/10/2016Q116($0.25)($0.20)$4.99 million$4.60 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/23/2016Q4($0.28)($0.18)$5.30 million$4.80 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/5/2015Q315($0.29)($0.25)$5.44 million$5.00 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/6/2015Q215($0.30)($0.27)$2.85 million$3.10 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/14/2015Q115($0.34)($0.21)$2.37 million$2.10 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/24/2015Q414($0.31)($0.34)$1.70 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
10/30/2014Q3 14($0.31)($0.33)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/11/2014Q214($0.41)($0.39)$1.04 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/12/2014($0.40)($0.73)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
3/24/2014Q313($0.23)($1.68)$0.40 million$0.47 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Alliqua (NASDAQ:ALQA)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20162($0.29)($0.28)($0.29)
Q2 20162($0.27)($0.26)($0.27)
Q3 20162($0.26)($0.24)($0.25)
Q4 20162($0.25)($0.23)($0.24)
Q1 20171($0.25)($0.25)($0.25)
Q2 20171($0.23)($0.23)($0.23)
Q3 20171($0.19)($0.19)($0.19)
Q4 20171($0.17)($0.17)($0.17)
(Data provided by Zacks Investment Research)

Dividends

Dividend History for Alliqua (NASDAQ:ALQA)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Alliqua (NASDAQ:ALQA)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionActions
11/9/2015Brian M PosnerCFOBuy5,000$3.04$15,200.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/6/2015Bradford BartonCOOBuy5,000$2.97$14,850.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/6/2015David Ian JohnsonCEOBuy8,650$2.92$25,258.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/6/2015Jerome B ZeldisDirectorBuy14,000$2.91$40,740.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/6/2015Pellegrino PionatiInsiderBuy10,000$2.95$29,500.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/10/2015Brian M PosnerCFOBuy2,500$5.02$12,550.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/8/2015Bradford BartonCOOBuy3,000$5.25$15,750.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/27/2015David Ian JohnsonCEOBuy10,000$4.65$46,500.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/20/2015Brian M PosnerCFOBuy2,500$4.34$10,850.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/4/2015Corp /De/ CelgeneMajor ShareholderBuy659,340$4.55$2,999,997.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/15/2014Brian M PosnerCFOBuy2,000$4.94$9,880.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/13/2014Brian M PosnerCFOBuy3,000$6.92$20,760.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/14/2014Corp /De/ CelgeneMajor ShareholderBuy714,286$7.00$5,000,002.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/21/2013Kenneth L LondonerDirectorBuy219,500$0.07$15,365.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for Alliqua (NASDAQ:ALQA)
DateHeadline
07/23/16 06:40 AMEquity Roundup: Stock Performance Focus on Alliqua BioMedical, Inc. (NASDAQ:ALQA) - Press Telegraph
07/21/16 02:26 PMIncreased Stock Volatility Watch: Alliqua BioMedical, Inc. (NASDAQ:ALQA) - Engelwood Daily
07/21/16 02:26 PMAlliqua BioMedical, Inc. (NASDAQ:ALQA): Sell-Side Ratings and Company Earnings Glance - Engelwood Daily
07/21/16 02:26 PMBroker Outlook For Alliqua Inc (ALQA) - Fiscal Standard
07/19/16 02:25 PMAlliqua Biomedical DE (NASDAQ:ALQA) Shorted Shares Increased By 8.54% - Consumer Eagle
07/18/16 07:17 AMHow Many Alliqua Biomedical Inc (NASDAQ:ALQA)'s Analysts Are Bullish? - Consumer Eagle
07/17/16 07:11 AMNext Weeks Broker Price Targets For Alliqua Inc (ALQA) - Fiscal Standard
07/16/16 10:50 AMIncreased Volatility Noted on Shares of: Alliqua BioMedical, Inc. (NASDAQ:ALQA) - Engelwood Daily
07/14/16 02:54 PMEdited Transcript of ALQA earnings conference call or presentation 10-May-16 12:00pm GMT -
07/14/16 12:25 PMEdited Transcript of ALQA earnings conference call or presentation 23-Feb-16 1:00pm GMT -
07/13/16 07:56 PMStrong Sell Calls For Alliqua BioMedical, Inc. (NASDAQ:ALQA) At 0 - Investor Newswire
07/13/16 02:27 PMAlliqua BioMedical, Inc. (NASDAQ:ALQA) Earnings Concentration and Analyst Target Watch - Engelwood Daily
07/13/16 02:27 PMNew Broker Ratings For Alliqua Inc (ALQA) - FTSE News
07/13/16 10:31 AMAlliqua Biomedical DE (NASDAQ:ALQA) Shorted Shares Decreased By 17.25% - Press Telegraph
07/12/16 07:26 AMAnalyst Target and Average Rating Watch: Alliqua BioMedical, Inc. (NASDAQ:ALQA) - Press Telegraph
07/08/16 07:37 PMIncreased Volatility on Shares of: Alliqua BioMedical, Inc. (NASDAQ:ALQA) - Engelwood Daily
07/07/16 02:25 PMHeightened Volatility Check on: Alliqua BioMedical, Inc. (NASDAQ:ALQA) - Engelwood Daily
07/07/16 02:25 PMAlliqua (ALQA) Enters Agreement for Exclusive SORBION Products Distribution Rights - StreetInsider.com
07/07/16 10:22 AMAlliqua BioMedical, Inc. Announces Preliminary Second Quarter of Fiscal Year 2016 Revenue; Earnings Conference Call Scheduled for August 9th
07/07/16 10:22 AMAlliqua (ALQA) Enters Agreement for Exclusive SORBION Products Distribution Rights
07/06/16 02:27 PMCan Alliqua BioMedical, Inc. (NASDAQ:ALQA) Improve on the Earnings Front? - Engelwood Daily
07/05/16 02:25 PMShare Volatility in Focus: Alliqua BioMedical, Inc. (NASDAQ:ALQA) - Engelwood Daily
07/04/16 07:14 AMAlliqua Biomedical DE (NASDAQ:ALQA) Short Interest Decreased By 17.25% - Press Telegraph
07/01/16 07:41 PMAlliqua Inc (ALQA) Updated Price Targets - FTSE News
07/01/16 07:41 PMRecently Issued Stock Ratings For Alliqua Inc (ALQA) - Fiscal Standard
07/01/16 02:27 PMWill Alliqua BioMedical, Inc. (NASDAQ:ALQA) Surprise Analysts? - Investor Newswire
06/29/16 02:23 PMWatching Stock Volatility for: Alliqua BioMedical, Inc. (NASDAQ:ALQA) - Engelwood Daily
06/29/16 02:23 PMAlliqua Biomedical DE (NASDAQ:ALQA) Short Interest Decreased By 17.25% - Engelwood Daily
06/28/16 07:41 AMCovering the Bases on Alliqua BioMedical, Inc. (NASDAQ:ALQA): Where is the Stock Going? - Press Telegraph
06/27/16 02:48 PMStock Volatility in Review: Alliqua BioMedical, Inc. (NASDAQ:ALQA) - Engelwood Daily
06/26/16 07:27 AMHow Many Alliqua Biomedical Inc (NASDAQ:ALQA)'s Analysts Are Bearish? - Engelwood Daily
06/25/16 02:26 PMAlliqua Biomedical DE (NASDAQ:ALQA) Sellers Covered 17.25% of Their Shorts - Engelwood Daily
06/24/16 02:26 PMShare Volatility Check for: Alliqua BioMedical, Inc. (NASDAQ:ALQA) - Press Telegraph
06/23/16 10:16 AMStrong Buy Calls Count For Alliqua BioMedical, Inc. (NASDAQ:ALQA) At 5 - Investor Newswire
06/21/16 11:46 AMETF’s with exposure to Alliqua BioMedical, Inc. : June 21, 2016 -
06/07/16 04:27 PMETF’s with exposure to Alliqua BioMedical, Inc. : June 7, 2016 -
06/06/16 06:31 AMALLIQUA BIOMEDICAL, INC. Files SEC form 8-K, Other Events -
06/02/16 11:05 AMStock Review and Earnings Check on Alliqua BioMedical, Inc. (NASDAQ:ALQA) - HNN - Stock Review and Earnings Check on Alliqua BioMedical, Inc. (NASDAQ:ALQA)HNNCompany earnings are a good way to evaluate the company profitability. Currently, sell-side analysts are expecting Alliqua BioMedical, Inc. (NASDAQ:ALQA) to report quarterly EPS of $-0.24. The company's next earnings report is expected to be published ...and more »
05/31/16 02:27 PMShare Rating Focus on Alliqua BioMedical, Inc. (NASDAQ:ALQA) - HNN - Share Rating Focus on Alliqua BioMedical, Inc. (NASDAQ:ALQA)HNNThis stock research may entail following what professional equity analysts think about the company. Presently, Wall Street analysts have given a consensus stock rating of 1 on shares of Alliqua BioMedical, Inc. (NASDAQ:ALQA). Covering analysts will ...and more »
05/30/16 02:04 PMPerformance at a Glance on Alliqua BioMedical, Inc. (NASDAQ:ALQA) - HNN - Performance at a Glance on Alliqua BioMedical, Inc. (NASDAQ:ALQA)HNNWhen speculating how a given stock will perform in the future, it is important to look at how it has performed in the past. Today we will examine how Alliqua BioMedical, Inc. (NASDAQ:ALQA)'s stock has performed at various points in its past. Currently ...How Many Alliqua Biomedical Inc (NASDAQ:ALQA)'s Analysts Are Bullish?The PostZeke Capital Advisors Exits Position in Alliqua Biomedical Inc (ALQA)Market DigestAlliqua BioMedical, Inc. (NASDAQ:ALQA) Quarterly EPS From Continuing Operations Stands At $-0.2815Markets Dailyall 5 news articles »
05/19/16 05:55 PMETF’s with exposure to Alliqua BioMedical, Inc. : May 19, 2016 -
05/18/16 12:17 PMAlliqua BioMedical, Inc. :ALQA-US: Earnings Analysis: Q1, 2016 By the Numbers -
05/16/16 07:02 AMAlliqua BioMedical, Inc. to Attend Craig-Hallum Institutional Investor Conference - [at noodls] - YARDLEY, Pa., May 16, 2016 (GLOBE NEWSWIRE) -- Alliqua BioMedical, Inc. (NASDAQ:ALQA) ('Alliqua' or 'the Company'), a provider of advanced wound care products, today announced that David Johnson, Chief ...
05/10/16 06:10 AMAlliqua reports 1Q loss -
05/10/16 06:08 AMAlliqua BioMedical, Inc. Reports First Quarter Financial Results - [at noodls] - Revenue Growth of 120% year-over-year; Reaffirms Fiscal Year 2016 Guidance YARDLEY, Pa., May 10, 2016 (GLOBE NEWSWIRE) -- Alliqua BioMedical, Inc. (Nasdaq:ALQA) ('Alliqua' or 'the Company'), a provider ...
05/10/16 06:07 AMQ1 2016 Alliqua BioMedical Inc Earnings Release - Before Market Open -
05/06/16 01:33 PMALLIQUA BIOMEDICAL, INC. Files SEC form 8-K, Material Modification to Rights of Security Holders, Change in Directors -
02/23/16 07:10 AMAlliqua reports 4Q loss -
02/23/16 06:07 AMQ4 2015 Alliqua BioMedical Inc Earnings Release - Before Market Open -
02/23/16 06:00 AMAlliqua BioMedical, Inc. Reports Fourth Quarter and Fiscal Year 2015 Financial Results - [GlobeNewswire] - YARDLEY, Pa., Feb. 23, 2016-- Alliqua BioMedical, Inc., a provider of advanced wound care products, today announced financial results for the fourth quarter and fiscal year ended December 31, 2015.. Total ...

Social

About Alliqua

Alliqua logoAlliqua BioMedical, Inc. is a provider of advanced wound care solutions. The Company's businesses include advanced wound care and contract manufacturing. The Company operates through its subsidiaries, such as AquaMed Technologies, Inc. and Choice Therapeutics, Inc. The Company is engaged in developing a suite of advanced wound care solutions that will enable surgeons, clinicians and wound care practitioners to address the challenges in chronic and acute wounds. The Company utilizes hydrogel technology through which hydrogels are manufactured by introducing a hydrophilic polymer into water to create a feed mix. The Company's commercial wound care portfolio consists of over four product categories, such as Human Biologics; Antimicrobial Protection; Exudate Management and Contract Manufacturing. Human Biologics include BIOVANCE and Extracellular Matrix (ECM). Under Antimicrobial Protection, the Company offers TheraBond 3D Antimicrobial Barrier Systems and SilverSeal.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Drug Manufacturers - Major
  • Sub-Industry: N/A
  • Exchange: NASDAQ
  • Symbol: ALQA
  • CUSIP:
Key Metrics:
  • Previous Close: $1.13
  • 50 Day Moving Average: $1.15
  • 200 Day Moving Average: $1.13
  • P/E Ratio: N/A
  • P/E Growth: -0.08
  • Market Cap: $32.75M
  • Beta: 1.15
  • Current Year EPS Consensus Estimate: $-1.02 EPS
  • Next Year EPS Consensus Estimate: $-0.78 EPS
Additional Links:
Alliqua (NASDAQ:ALQA) Chart for Thursday, July, 28, 2016